A nurse is teaching a client who is to start taking clopidogrel. The nurse should instruct the client to monitor and report which of the following adverse effects of the medication?
Constipation
Weight loss
Bruising
Blurred vision
The Correct Answer is C
A. Constipation: Constipation is not a commonly reported adverse effect of clopidogrel.
Therefore, it is not necessary to instruct the client to monitor and report constipation as an adverse effect.
B. Weight loss: Weight loss is not a commonly reported adverse effect of clopidogrel. Therefore, it is not necessary to instruct the client to monitor and report weight loss as an adverse effect.
C. Bruising: Clopidogrel is an antiplatelet medication that inhibits platelet aggregation.
Therefore, one of the potential adverse effects is an increased risk of bleeding, which can
manifest as easy bruising or prolonged bleeding from minor injuries. Instructing the client to monitor and report bruising is important for early detection of bleeding complications.
D. Blurred vision: Blurred vision is not a commonly reported adverse effect of clopidogrel.
Therefore, it is not necessary to instruct the client to monitor and report blurred vision as an adverse effect.
Nursing Test Bank
Naxlex Comprehensive Predictor Exams
Related Questions
Correct Answer is B
Explanation
A. Warming the formula to room temperature would not address hyperkalemia.
B. Hyperkalemia can lead to cardiac dysrhythmias, so placing the client on a cardiac monitor
allows for continuous cardiac monitoring to detect any changes or abnormalities in heart rhythm.
C. Administering IV dextrose is not typically indicated for hyperkalemia. Instead, insulin may be administered with dextrose to promote cellular uptake of potassium.
D. Requesting a lactose-free formula is not relevant to the management of hyperkalemia.
Correct Answer is D
Explanation
A. Verapamil: Verapamil is a calcium channel blocker primarily used to treat supraventricular
tachycardias, not ventricular dysrhythmias. It is not typically used for life-threatening ventricular dysrhythmias.
B. Digoxin: Digoxin is a cardiac glycoside used primarily for atrial fibrillation and heart failure, not ventricular dysrhythmias. It is not typically used for life-threatening ventricular
dysrhythmias.
C. Dopamine: Dopamine is a sympathomimetic medication used for hemodynamic support in hypotension and shock. While it may be used in some cases of unstable bradycardia, it is not the first-line medication for life-threatening ventricular dysrhythmias.
D. Amiodarone: Amiodarone is an antiarrhythmic medication used for the treatment of various ventricular and supraventricular dysrhythmias, including life-threatening ventricular
dysrhythmias such as ventricular tachycardia and ventricular fibrillation. It is often used as a first-line medication for these conditions due to its efficacy and safety profile. Therefore, the nurse should anticipate administering amiodarone for the client's life-threatening ventricular dysrhythmia.
Whether you are a student looking to ace your exams or a practicing nurse seeking to enhance your expertise , our nursing education contents will empower you with the confidence and competence to make a difference in the lives of patients and become a respected leader in the healthcare field.
Visit Naxlex, invest in your future and unlock endless possibilities with our unparalleled nursing education contents today
Report Wrong Answer on the Current Question
Do you disagree with the answer? If yes, what is your expected answer? Explain.
Kindly be descriptive with the issue you are facing.